TABLE III.
Univariate and multivariate analysis of high EVI1 expression and cytogenetic / molecular risk groups
| Univariate Cox Analyses | ||||||||
|---|---|---|---|---|---|---|---|---|
| OS from study entry | DFS from end of course 1 | |||||||
| N | HR | 95% CI | p | N | HR | 95% CI | p | |
| EVI1 Expression | ||||||||
| Low / Absent EVI1 | 148 | 1 | 118 | 1 | ||||
| High EVI1 | 58 | 1.79 | 1.11 – 2.89 | 0.016 | 40 | 1.48 | 0.88 – 2.49 | 0.142 |
| Risk group | ||||||||
| Standard | 99 | 1 | 70 | 1 | ||||
| Favourable | 70 | 0.31 | 0.16 – 0.59 | <0.001 | 59 | 0.55 | 0.31 – 0.98 | 0.043 |
| High | 26 | 1.72 | 0.97 – 3.07 | 0.065 | 19 | 1.72 | 0.89 – 3.35 | 0.108 |
| Multivariate Cox Analyses | ||||||||
| OS from study entry | DFS from end of course 1 | |||||||
| N | HR | 95% CI | p | N | HR | 95% CI | p | |
| EVI1 Expression | ||||||||
| Low / Absent EVI1 | 141 | 1 | 111 | 1 | ||||
| High EVI1 | 54 | 1.17 | 0.70 – 1.96 | 0.554 | 37 | 1.11 | 0.61 – 2.01 | 0.728 |
| Risk group | ||||||||
| Standard | 99 | 1 | 70 | 1 | ||||
| Favourable | 70 | 0.33 | 0.16 – 0.65 | 0.002 | 59 | 0.58 | 0.31 – 1.08 | 0.087 |
| High | 26 | 1.76 | 0.99 – 3.14 | 0.056 | 19 | 1.76 | 0.91 – 3.44 | 0.096 |